The Evolution of Biosimilar Markets: Key Elements for Long-Term Sustainability of the Healthcare Ecosystem
Moderator: Teresa Barcina, PharmD, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, VBR, Belgium
Speakers: Cate Lockhart, PharmD, PhD, Biologics and Biosimilars Collective Intelligence Consortium, Asheville, NC, USA; Jacqueline Vanderpuye-Orgle, MSc, PhD, Parexel International LLC, Massachusetts, MA, USA; Murray Aitken, MBA, IQVIA Institute for Human Data Science and the London School of Economics and Political Science, New York, NY, USA; Anna Hyde, MA, Advocacy and Access, Arthritis Foundation, Silver Spring, MD, USA
This Forum addresses topics of interest for the ISPOR Biosimilars Special Interest Group and will follow the structure of a panel. Cate Lockhart will introduce the session and provide the US perspective on elements that may undermine the long-term sustainability of off-patent biologic and biosimilar markets. Murray Aitken will share insights from IQVIA on building frameworks to evaluate sustainability risks. Jackie Vanderpuye-Orgle will discuss elements needed to reach consensus on long-term sustainability objectives. Anna Hyde will comment on these sustainability objectives from the patients’ advocate perspective. Each speaker (10 minutes allocated per presentation) will raise a question to be addressed by the audience via a real-time polling system. After the speakers’ presentations, Teresa Barcina will moderate a Q&A session that will be structured around the answers of the audience to the poll questions.
Conference/Value in Health Info